JDRF's Focus Areas

Research
JDRF has been part of every advancement in type 1 diabetes (T1D) care in the last 50 years. As the world’s largest funder of T1D research, we collaborate, connect and co-ordinate the world’s greatest minds to deliver tangible improvements for the T1D community.

Advocacy
Through our tireless representation of the challenges facing the T1D community we have, in partnership with our advocates, delivered real change. We have changed how Governments view type 1 diabetes and delivered nearly $500m in new investment in T1D in 10 years.

Community
A community driven organisation founded to support Australians living with type 1 diabetes, the T1D community is our focus. From first diagnosis through to living with T1D as an adult, our resources, staff, and community are with you each step of the way.

Fundraising
Changing the world is challenging and expensive. People from a range of backgrounds have provided JDRF significant support, whether it is leaving a bequest or participating in events like the One Walk. These funds have been crucial for supporting research.
Get the latest updates from JDRF as we lead the fight against type 1 diabetes
What JDRF has achieved

25 years
added to the life expectancy of a child diagnosed with T1D.
The researchers changing the future of type 1 diabetes
JDRF-funded Professors Jenny Couper, Simon Barry and Toby Coates on their research projects and their hopes for the future of T1D.